Cart
sales@molnova.com
SLU-PP-1072
CAS No. 2285432-57-5
SLU-PP-1072( —— )
Catalog No. M36943 CAS No. 2285432-57-5
SLU-PP-1072 is an ERRα and ERRγ inverse dual agonist that disrupts PCa cell metabolism and induces apoptosis through cell cycle dysregulation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 73 | Get Quote |
|
| 5MG | 116 | Get Quote |
|
| 10MG | 187 | Get Quote |
|
| 25MG | 365 | Get Quote |
|
| 50MG | 542 | Get Quote |
|
| 100MG | 759 | Get Quote |
|
| 500MG | 1557 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSLU-PP-1072
-
NoteResearch use only, not for human use.
-
Brief DescriptionSLU-PP-1072 is an ERRα and ERRγ inverse dual agonist that disrupts PCa cell metabolism and induces apoptosis through cell cycle dysregulation.
-
DescriptionSLU-PP-1072 is a dual ERRα/γ inverse agonist, used in Prostate cancer (PCa) research. SLU-PP-1072 disrupts PCa cell metabolism, and induces apoptosis via dysregulating cell cycle.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | Estrogen/progestogen Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2285432-57-5
-
Formula Weight336.36
-
Molecular FormulaC18H12N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (371.63 mM; Ultrasonic )
-
SMILESC(NC=1C=C2C(=CC1)N=CS2)(=O)C=3OC(=CC3)C4=CC=C(O)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schoepke E, et al. A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells. ACS Chem Biol. 2020 Sep 18;15(9):2338-2345.?
molnova catalog
related products
-
Ginsenoside Rg6
Ginsenoside Rg6 inhibits the proliferation and induces apoptosis of human lymphoma JK cells
-
RH1
RH1 (NSC 697726) is a bioreductive anticancer compound that exhibits dose-dependent biphasic effects in vitro, inducing apoptosis at higher doses and senescence at lower doses.
-
Pipobroman
Pipobroman is an anti-cancer drug that probably acts as an alkylating agent.
